Botox injections into the thyroarytenoid muscle are a predictable and effective treatment for
SD, but typically result in transient symptoms of voice weakness and breathiness during the
first 2-3 weeks after injection. We hypothesize that voice weakness and breathiness after
Botox treatment can be alleviated using amifampridine.